Literature DB >> 2166983

Disorders induced by the experimental infection of pigs with the porcine respiratory coronavirus (P.R.C.V.).

P Vannier1.   

Abstract

Five colostrum deprived hysterectomy-derived piglets were inoculated by the intratracheal route with a Porcine Respiratory Coronavirus (PRCV). The clinical effects and growth performances were compared with those in 5 similar piglets which were inoculated with Minimum Eagle Medium only. A transient hyperthermia, mild to severe dyspnoea, polypnoea and an obvious cessation of growth were recorded on infected pigs only whereas the control group did not show any adverse reaction after inoculation. The reasons for the variability of effects of experimental infection observed in previous trials, are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2166983     DOI: 10.1111/j.1439-0450.1990.tb01043.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  5 in total

1.  Porcine respiratory coronavirus in Quebec: Serological studies using a competitive inhibition enzyme-linked immunosorbent assay.

Authors:  A Jabrane; Y Elazhary; B G Talbot; R Ethier; C Dubuc; R Assaf
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

2.  Seroprevalence of porcine respiratory coronavirus in selected Korean pigs.

Authors:  C Chae; O Kim; K Min; C Choi; J Kim; W Cho
Journal:  Prev Vet Med       Date:  2000-09-01       Impact factor: 2.670

3.  Pathogenicity of concurrent infection of pigs with porcine respiratory coronavirus and swine influenza virus.

Authors:  I Lanza; I H Brown; D J Paton
Journal:  Res Vet Sci       Date:  1992-11       Impact factor: 2.534

4.  Experimental infection of pigs with the porcine respiratory coronavirus (PRCV): measure of viral excretion.

Authors:  E Bourgueil; E Hutet; R Cariolet; P Vannier
Journal:  Vet Microbiol       Date:  1992-04       Impact factor: 3.293

Review 5.  Porcine Coronaviruses: Overview of the State of the Art.

Authors:  Hanna Turlewicz-Podbielska; Małgorzata Pomorska-Mól
Journal:  Virol Sin       Date:  2021-03-15       Impact factor: 4.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.